Company profile
Stemtech Corp CIK 1511820
Ticker
STEK (OTC)
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Headquarters
Naples, FL 34103
Fiscal year end
2025 (FY)
Key Financials
Revenue
$2.88M
Net income
-$4.05M
Total assets
$3.15M
Total liabilities
$10.59M
Stockholders' equity
-$6.96M
Cash & equivalents
$238.2K
Operating income
-$2.71M
Operating cash flow
-$483.6K
Capital expenditures
$0
Fiscal year 2025, via 10-K filed 2026-05-29. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-94.2%
Net margin
-140.7%
Free cash flow
-$483.6K
Free cash flow margin
-16.8%
Liabilities / assets
336.1%
Equity / assets
-220.9%
CapEx / revenue
0.0%
Operating cash flow / net income
0.12×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$2.88M
-$4.05M
$3.15M
$10.59M
-$6.96M
2024
$5.05M
-$3.77M
$3.78M
$8.74M
-$4.48M
2023
$4.92M
-$5.43M
$3.68M
$6.46M
-$2.04M
2022
$4.56M
-$8.54M
$4.27M
$7.44M
-$2.43M
2021
$4.32M
-$7.08M
$5.72M
$9.73M
-$3.36M
Company Details
SIC code
5122
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-05-29
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Naples, FL 34103
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.